No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients
Gespeichert in:
Veröffentlicht in: | Multiple sclerosis 2010, Vol.16 (3), p.366-369 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 369 |
---|---|
container_issue | 3 |
container_start_page | 366 |
container_title | Multiple sclerosis |
container_volume | 16 |
creator | REUSS, R SCHREIBER, V KLEIN, A INFANTE-DUARTE, C FILIPPI, M PABST, W POHL, C OSCHMANN, P |
description | |
format | Article |
fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_22572056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22572056</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_225720563</originalsourceid><addsrcrecordid>eNqNjE1KBDEQhRtRcPy5Q21cNsTuidG1KLpx5X4oMpWe0uokpNLg7LyEB_FKnsQoHsDV-3h87x10q8u1c725ceaw8WiHfm2v7XF3ovpijHFutKvu8ymB8hQ5sMdYgUIgXyEFSAVF9oDbmSNrpUJb8Dua0ytHgkKeck0FHqHNcEo_DqQIHJvqSWQRLG29I-VWz0nIL0L9CPSWC-lvy7EdCWblOH29fxSaudbGMC9SOQuBeqGSlBUyVqZY9aw7CihK53952l3c3z3fPvQZ1aOEgtGzbnLhGct-MwzWDcZejf_1vgHlOWmf</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><source>SAGE Complete A-Z List</source><creator>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</creator><creatorcontrib>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</creatorcontrib><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><language>eng</language><publisher>London: Sage Publications</publisher><subject>Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Medical sciences ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology</subject><ispartof>Multiple sclerosis, 2010, Vol.16 (3), p.366-369</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22572056$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>REUSS, R</creatorcontrib><creatorcontrib>SCHREIBER, V</creatorcontrib><creatorcontrib>KLEIN, A</creatorcontrib><creatorcontrib>INFANTE-DUARTE, C</creatorcontrib><creatorcontrib>FILIPPI, M</creatorcontrib><creatorcontrib>PABST, W</creatorcontrib><creatorcontrib>POHL, C</creatorcontrib><creatorcontrib>OSCHMANN, P</creatorcontrib><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><title>Multiple sclerosis</title><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Medical sciences</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNjE1KBDEQhRtRcPy5Q21cNsTuidG1KLpx5X4oMpWe0uokpNLg7LyEB_FKnsQoHsDV-3h87x10q8u1c725ceaw8WiHfm2v7XF3ovpijHFutKvu8ymB8hQ5sMdYgUIgXyEFSAVF9oDbmSNrpUJb8Dua0ytHgkKeck0FHqHNcEo_DqQIHJvqSWQRLG29I-VWz0nIL0L9CPSWC-lvy7EdCWblOH29fxSaudbGMC9SOQuBeqGSlBUyVqZY9aw7CihK53952l3c3z3fPvQZ1aOEgtGzbnLhGct-MwzWDcZejf_1vgHlOWmf</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>REUSS, R</creator><creator>SCHREIBER, V</creator><creator>KLEIN, A</creator><creator>INFANTE-DUARTE, C</creator><creator>FILIPPI, M</creator><creator>PABST, W</creator><creator>POHL, C</creator><creator>OSCHMANN, P</creator><general>Sage Publications</general><scope>IQODW</scope></search><sort><creationdate>2010</creationdate><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><author>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_225720563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Medical sciences</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>REUSS, R</creatorcontrib><creatorcontrib>SCHREIBER, V</creatorcontrib><creatorcontrib>KLEIN, A</creatorcontrib><creatorcontrib>INFANTE-DUARTE, C</creatorcontrib><creatorcontrib>FILIPPI, M</creatorcontrib><creatorcontrib>PABST, W</creatorcontrib><creatorcontrib>POHL, C</creatorcontrib><creatorcontrib>OSCHMANN, P</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>REUSS, R</au><au>SCHREIBER, V</au><au>KLEIN, A</au><au>INFANTE-DUARTE, C</au><au>FILIPPI, M</au><au>PABST, W</au><au>POHL, C</au><au>OSCHMANN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</atitle><jtitle>Multiple sclerosis</jtitle><date>2010</date><risdate>2010</risdate><volume>16</volume><issue>3</issue><spage>366</spage><epage>369</epage><pages>366-369</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><cop>London</cop><pub>Sage Publications</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1352-4585 |
ispartof | Multiple sclerosis, 2010, Vol.16 (3), p.366-369 |
issn | 1352-4585 1477-0970 |
language | eng |
recordid | cdi_pascalfrancis_primary_22572056 |
source | SAGE Complete A-Z List |
subjects | Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology |
title | No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20significant%20effect%20of%20orally%20administered%20chemokine%20receptor%20I%20antagonist%20on%20intercellular%20adhesion%20molecule-3%20expression%20in%20relapsing%E2%80%95remitting%20multiple%20sclerosis%20patients&rft.jtitle=Multiple%20sclerosis&rft.au=REUSS,%20R&rft.date=2010&rft.volume=16&rft.issue=3&rft.spage=366&rft.epage=369&rft.pages=366-369&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E22572056%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |